Exhibit 99.1
Prestige Brands Holdings, Inc. Reports First Quarter Fiscal 2009 Results
Irvington, NY, August 7, 2008—Prestige Brands Holdings, Inc. (NYSE-PBH), a consumer products company with a diversified portfolio of well-known brands, today announced results for the first quarter of fiscal year 2009, which ended on June 30, 2008.
Total revenues for the first fiscal quarter ended June 30, 2008 were $73.5 million, a 6.5% decrease from total revenues of $78.6 million in the prior year comparable quarter. As indicated in our news release of July 23rd, this decline is largely attributable to pricing dynamics in the cryogenic segment of the over-the-counter wart treatment category affecting our Compound W® and Wartner® brands. A secondary factor is the continued absence of the Little Remedies® pediatric cough/cold products, which were voluntarily withdrawn from the marketplace in the fall of calendar year 2007. In addition, The Doctor’s® NightGuard™ brand continued to experience declining sales due to the competition which came into the marketplace in last fiscal year’s first quarter.
Operating income of $21.2 million for the first quarter was $1.9 million, or 8.2% below last year’s operating income of $23.1 million. The decline from last year was due to the sales decline, partially offset by favorable cost of sales and lower advertising and promotion expenses. G&A expenses were higher than prior year, primarily due to increased stock based compensation expenses.
Interest expense of $8.8 million was $1.1 million lower than prior year due to lower debt outstanding, the Company having repaid $52.1 million during the previous fiscal year.
Net income for the first quarter was $7.8 million, or $0.16 fully diluted earnings per share, 6.5% below last year’s reported net income of $8.3 million, or $0.17 fully diluted earnings per share.
Results by Segment for the First Fiscal Quarter
Over-the-Counter Healthcare Products
Revenues of $39.2 million were $3.2 million or 7.5% less than the prior year comparable period. The decline is primarily attributable to sales declines on the Compound W® and Wartner® wart treatment brands, largely attributed to negative pricing dynamics in the cryogenic segment. The continued absence of the Little Remedies® pediatric cough/cold products voluntarily withdrawn in the fall of calendar year 2007 and The Doctor’s® Night Guard™ brand, which continued to experience intense competitive
pressures, were secondary factors. These declines were partially offset by increases on the Clear Eyes®, Murine™ ear care, Chloraseptic® and New Skin® brands.
Household Products
Revenues of $29.0 million were $0.9 million or $2.9% less than the prior year period. Sales increases for the Comet® brand, led by Comet Mildew SprayGel were offset by declines in the Spic and Span® and Chore Boy® brands.
Personal Care Products
Revenues for this segment were $5.3 million, $1.0 million less than the prior year quarter, in line with expectations.
Free Cash Flow & Debt Repayment
Free cash flow is a “non-GAAP” measure as that term is defined by the Securities and Exchange Commission in Regulation G. Free cash flow is presented here because management believes it is a commonly used measure of liquidity, and is an indication of cash available for debt repayment and acquisitions. The Company defines free cash flow as operating cash flow less capital expenditures.
The Company’s free cash flow for the first quarter ended June 30, 2008 was $15.3 million, composed of operating cash flow of $15.4 million less capital expenditures of $0.1 million, a $7.0 million increase over free cash flow of $8.3 million, composed of operating cash flow of $8.4 million less capital expenditures of $0.1 million generated in the prior year comparable quarter. During the quarter, the Company repaid $15.0 million of senior bank debt, bringing total debt to $396.2 million at June 30, 2008.
Commentary
According to Mark Pettie, Chairman and CEO, “Despite this quarter’s results, we remain confident in the 2-4% revenue increase we have projected for the full fiscal year, with strengthened third and fourth quarter growth in particular. We expect this performance will be fueled by our innovative new products, many of which are currently launching, as well as continued growth of our focus brands. For the full year, we expect that net income will grow more rapidly than revenue. Looking at the current quarter, we will be investing heavily in advertising and promotion support behind our new Allergen Block products. Much of the revenue impact from this increased second quarter advertising and promotion support will be realized in the second half”.
-2-
Conference Call
The Company will host a conference call to review its first fiscal quarter results on Thursday, August 7th at 8:30 a.m. EST. The dial in number is 866-578-5801. International callers may dial 617-213-8058. The passcode is "prestige". The Company will provide a live internet webcast of the call, as well as an archived replay, which can be accessed by dialing 888-286-8010, or for international callers, 617-801-6888. The passcode for replay only is 53732046.
About Prestige Brands Holdings, Inc.
Located in Irvington, New York, Prestige Brands Holdings, Inc. is a marketer and distributor of brand name over-the-counter healthcare, personal care and household cleaning products sold throughout the U.S., Canada, and in certain international markets. Key brands include Compound W® wart remover, Chloraseptic® sore throat treatments, New-Skin® liquid bandage, Clear Eyes® and Murine® eye and ear care products, Little Remedies® pediatric over-the-counter products, The Doctor’s® NightGuard™ dental protector, Cutex® nail polish remover, Comet® and Spic and Span® household cleaners, and other well-known brands.
Forward-Looking Statements
Note: This news release contains "forward-looking statements" within the meaning of the federal securities laws and is intended to qualify for the Safe Harbor from liability established by the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" generally can be identified by the use of forward-looking terminology such as "assumptions," "target," "guidance," "outlook," "plans," "projection," "may," "will," "would," "expect," "intend," "estimate," "anticipate," "believe," "potential," or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. The "forward-looking statements" include, without limitation, statements regarding the outlook for Prestige Brands Holdings' market and the demand for its products, earnings per share, future cash flows from operations, future revenues and margin requirement and expansion, the success of new product introductions, growth in costs and expenses, and the impact of acquisitions, divestitures, restructurings and other unusual items, including Prestige Brands Holdings' ability to integrate and obtain the anticipated results and synergies from its acquisitions. These projections and statements are based on management's estimates and assumptions with respect to future events and financial performance and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results could differ materially from those projected as a result of certain factors. A discussion of factors that could
-3-
cause results to vary is included in the Company's Annual Report on Form 10-K and other periodic and other reports filed with the Securities and Exchange Commission.
Contact: Dean Siegal
914-524-6819
-4-
Prestige Brands Holdings, Inc.
Consolidated Statements of Operations
(Unaudited)
| Three Months Ended June 30 | ||||||||
| (In thousands, except share data) | 2008 | 2007 | ||||||
| Revenues | ||||||||
| Net sales | $ | 72,916 | $ | 78,041 | ||||
| Other revenues | 618 | 570 | ||||||
| Total revenues | 73,534 | 78,611 | ||||||
| Costs of Sales | ||||||||
| Costs of sales | 34,272 | 37,322 | ||||||
| Gross profit | 39,262 | 41,289 | ||||||
| Operating Expenses | ||||||||
| Advertising and promotion | 7,319 | 7,786 | ||||||
| General and administrative | 7,973 | 7,646 | ||||||
| Depreciation and amortization | 2,756 | 2,751 | ||||||
| Total operating expenses | 18,048 | 18,183 | ||||||
| Operating income | 21,214 | 23,106 | ||||||
| Other (income) expense | ||||||||
| Interest income | (73 | ) | (187 | ) | ||||
| Interest expense | 8,756 | 9,874 | ||||||
| Total other (income) expense | 8,683 | 9,687 | ||||||
| Income before income taxes | 12,531 | 13,419 | ||||||
| Provision for income taxes | 4,750 | 5,099 | ||||||
| Net income | $ | 7,781 | $ | 8,320 | ||||
| Basic earnings per share | $ | 0.16 | $ | 0.17 | ||||
| Diluted earnings per share | $ | 0.16 | $ | 0.17 | ||||
| Weighted average shares outstanding: | ||||||||
| Basic | 49,880 | 49,660 | ||||||
| Diluted | 50,035 | 50,038 | ||||||
-5-
Prestige Brands Holdings, Inc.
Consolidated Balance Sheets
(Unaudited)
(In thousands)
| Assets | June 30, 2008 | March 31, 2008 | ||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 6,370 | $ | 6,078 | ||||
| Accounts receivable | 38,325 | 44,219 | ||||||
| Inventories | 28,811 | 29,696 | ||||||
| Deferred income tax assets | 3,006 | 3,066 | ||||||
| Prepaid expenses and other current assets | 4,004 | 2,316 | ||||||
| Total current assets | 80,516 | 85,375 | ||||||
| Property and equipment | 1,365 | 1,433 | ||||||
| Goodwill | 308,915 | 308,915 | ||||||
| Intangible assets | 644,056 | 646,683 | ||||||
| Other long-term assets | 7,316 | 6,750 | ||||||
| Total Assets | $ | 1,042,168 | $ | 1,049,156 | ||||
| Liabilities and Stockholders’ Equity | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ | 17,935 | $ | 20,539 | ||||
| Accrued interest payable | 2,604 | 5,772 | ||||||
| Income taxes payable | 1,762 | -- | ||||||
| Other accrued liabilities | 6,328 | 8,030 | ||||||
| Current portion of long-term debt | 3,550 | 3,550 | ||||||
| Total current liabilities | 32,179 | 37,891 | ||||||
| Long-term debt | 392,675 | 407,675 | ||||||
| Other long-term liabilities | 2,377 | 2,377 | ||||||
| Deferred income tax liabilities | 125,781 | 122,140 | ||||||
| Total Liabilities | 553,012 | 570,083 | ||||||
| Stockholders’ Equity | ||||||||
| Preferred stock - $0.01 par value | ||||||||
Authorized – 5,000 shares | ||||||||
Issued and outstanding – None | -- | -- | ||||||
| Common stock - $0.01 par value | ||||||||
Authorized – 250,000 shares | ||||||||
Issued – 50,060 shares at June 30 and March 31, 2008 | 501 | 501 | ||||||
| Additional paid-in capital | 380,993 | 380,364 | ||||||
| Treasury stock, at cost – 101 shares and 59 shares at June 30 and March 31, 2008, respectively | (57 | ) | (47 | ) | ||||
| Accumulated other comprehensive income | 684 | (999 | ) | |||||
| Retained earnings | 107,035 | 99,254 | ||||||
| Total stockholders’ equity | 489,156 | 479,073 | ||||||
| Total Liabilities and Stockholders’ Equity | $ | 1,042,168 | $ | 1,049,156 | ||||
-6-
Prestige Brands Holdings, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
| Three Months Ended June 30 | ||||||||
| (In thousands) | 2008 | 2007 | ||||||
| Operating Activities | ||||||||
| Net income | $ | 7,781 | $ | 8,320 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 2,756 | 2,751 | ||||||
| Deferred income taxes | 2,669 | 2,934 | ||||||
| Amortization of deferred financing costs | 622 | 780 | ||||||
| Stock-based compensation | 629 | 460 | ||||||
| Changes in operating assets and liabilities | ||||||||
| Accounts receivable | 5,894 | (1,948 | ) | |||||
| Inventories | 885 | 1,663 | ||||||
| Prepaid expenses and other current assets | (1,688 | ) | (483 | ) | ||||
| Accounts payable | (1,077 | ) | (2,911 | ) | ||||
| Income taxes payable | 1,762 | 1,144 | ||||||
| Accrued liabilities | (4,870 | ) | (4,302 | ) | ||||
| Net cash provided by operating activities | 15,363 | 8,408 | ||||||
| Investing Activities | ||||||||
| Purchases of equipment | (61 | ) | (111 | ) | ||||
| Net cash used for investing activities | (61 | ) | (111 | ) | ||||
| Financing Activities | ||||||||
| Repayment of long-term debt | (15,000 | ) | (15,887 | ) | ||||
| Purchase of common stock for treasury | (10 | ) | (4 | ) | ||||
| Net cash used for financing activities | (15,010 | ) | (15,891 | ) | ||||
| Increase (Decrease) in cash | 292 | (7,594 | ) | |||||
| Cash - beginning of period | 6,078 | 13,758 | ||||||
| Cash - end of period | $ | 6,370 | $ | 6,164 | ||||
| Interest paid | $ | 11,302 | $ | 12,036 | ||||
| Income taxes paid | $ | 440 | $ | 551 | ||||
-7-
Prestige Brands Holdings, Inc.
Consolidating Statements of Operations
(Unaudited)
| Three Months Ended June 30, 2008 | ||||||||||||||||
Over-the- Counter Healthcare | Household Cleaning | Personal Care | Consolidated | |||||||||||||
| Net sales | $ | 39,246 | $ | 28,404 | $ | 5,266 | $ | 72,916 | ||||||||
| Other revenues | -- | 618 | -- | 618 | ||||||||||||
| Total revenues | 39,246 | 29,022 | 5,266 | 73,534 | ||||||||||||
| Cost of sales | 13,208 | 17,923 | 3,141 | 34,272 | ||||||||||||
| Gross profit | 26,038 | 11,099 | 2,125 | 39,262 | ||||||||||||
| Advertising and promotion | 5,037 | 2,070 | 212 | 7,319 | ||||||||||||
| Contribution margin | $ | 21,001 | $ | 9,029 | $ | 1,913 | 31,943 | |||||||||
| Other operating expenses | 10,729 | |||||||||||||||
| Operating income | 21,214 | |||||||||||||||
| Other (income) expense | 8,683 | |||||||||||||||
| Provision for income taxes | 4,750 | |||||||||||||||
| Net income | $ | 7,781 | ||||||||||||||
| Three Months Ended June 30, 2007 | ||||||||||||||||
Over-the- Counter | Household | Personal | ||||||||||||||
| Healthcare | Cleaning | Care | Consolidated | |||||||||||||
| Net sales | $ | 42,426 | $ | 29,345 | $ | 6,270 | $ | 78,041 | ||||||||
| Other revenues | -- | 542 | 28 | 570 | ||||||||||||
| Total revenues | 42,426 | 29,887 | 6,298 | 78,611 | ||||||||||||
| Cost of sales | 15,386 | 18,393 | 3,543 | 37,322 | ||||||||||||
| Gross profit | 27,040 | 11,494 | 2,755 | 41,289 | ||||||||||||
| Advertising and promotion | 5,881 | 1,628 | 277 | 7,786 | ||||||||||||
| Contribution margin | $ | 21,159 | $ | 9,866 | $ | 2,478 | 33,503 | |||||||||
| Other operating expenses | 10,397 | |||||||||||||||
| Operating income | 23,106 | |||||||||||||||
| Other (income) expense | 9,687 | |||||||||||||||
| Provision for income taxes | 5,099 | |||||||||||||||
| Net income | $ | 8,320 | ||||||||||||||
-8-